查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1362868

呼吸道融合細胞病毒診斷市場規模、佔有率和趨勢分析報告：2023-2030 年按產品、最終用途、地區和細分市場分類的趨勢

Respiratory Syncytial Virus Diagnostics Market Size, Share & Trends Analysis Report By Product (DFA, RADT, Molecular Diagnostics, Chromatographic Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 118 Pages | 商品交期: 2-10個工作天內

價格

呼吸道融合細胞病毒診斷市場成長與趨勢：

Grand View Research, Inc. 的一項新研究顯示，到 2030 年，全球呼吸道融合細胞病毒診斷市場預計將達到 19.473 億美元，2023 年至 2030 年年複合成長率預計為 9.7%。

罹患呼吸道疾病（包括 RSV感染疾病）的新生兒人數不斷增加，以及醫療保健提供者對新生兒診斷的支持舉措預計將成為 RSV 診斷市場的關鍵影響促進因素。

根據世界衛生組織統計，2014年美國有超過15萬名兒童（5歲以下）因RSV感染疾病住院，約1.4萬名老年患者死亡。預計這將推動預測期內對這些疾病的檢測需求。

此外，截至2014年，全球出生率為每1,000人18.7個孩子，預計未來年度嬰幼兒人口將大幅增加。根據統計，2014年估計約有1.342億生產，這些生產由於容易感染疾病RSV並需要診斷，形成了龐大的市場基礎。

2010 年，透過篩檢拯救嬰兒基金會 (SBTS) 與世界傳染病解決方案 (WSAID) 合作發起了一項計劃，以促進新生兒感染疾病、代謝紊亂和聽力損失篩檢。

呼吸道融合細胞病毒診斷市場報告亮點

  • 基於色譜免疫檢測技術的產品預計將成長最快，未來年度年複合成長率將超過10.0%，因為它們比分子診斷產品更具特異性。市售檢測套組包括 Binax Now RSV、QuickLab RSV Test、Remel Xpect 和 RSV Respi-Strip。
  • 醫院預計將主導 RSV 診斷市場，其次是居家醫療。預計到 2022 年，它們將佔據超過 50.0% 的市場佔有率。患者對居家醫療診斷設備的需求增加預計將在未來年度推動該領域的成長。
  • 預計到 2022 年，北美將佔據市場主導地位，佔據超過 41.5% 的銷售佔有率。民眾對啟動和實施新生兒篩檢的認知不斷提高，以及世界衛生組織、泛美衛生組織和 WSAID 等政府機構的有利配合措施預計將推動成長。
  • 市場的主要企業包括 Alere Inc.、EMD Millipore、BD and Company、Ortho Clinical Diagnostics、Roche Diagnostics、Abbott Laboratories 和 Thermo Fisher Scientific Inc.。 Roche Diagnostics、Becton Dickinson and Company 和 Alere Inc. 等公司的 CLIA 批准和 RSV 檢測的推出預計將在預測期內推動市場成長。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 呼吸道融合細胞病毒(RSV) 診斷市場變數、趨勢與範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 普及和成長預測圖
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 呼吸道融合細胞病毒（RSV）診斷市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 呼吸道融合細胞病毒（RSV）診斷市場：產品評估與趨勢分析

  • 呼吸道融合細胞病毒(RSV) 診斷市場：重點
  • 呼吸道融合細胞病毒(RSV) 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 直接螢光抗體（DFA）法
  • 快速抗原診斷測試 (RADT)
  • 分子診斷
  • 層析免疫分析法
  • 影像診斷
  • 凝膠微滴
  • 流式細胞儀
  • 其他

第5章 呼吸道融合細胞病毒（RSV）診斷市場：最終用途估計與趨勢分析

  • 呼吸道融合細胞病毒(RSV) 診斷市場：重點
  • 呼吸道融合細胞病毒(RSV) 診斷市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 醫院
  • 實驗室
  • 診所
  • 居家護理

第6章 呼吸道融合細胞病毒（RSV）診斷市場：區域估計與趨勢分析

  • 區域展望
  • 按地區分類的呼吸道融合細胞病毒(RSV) 診斷市場：主要市場點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Becton, Dickinson and Company
    • Novartis AG
    • Abbott
    • Ortho Clinical Diagnostics
    • Thermo Fisher Scientific Inc.
    • Bio-Rad Laboratories, Inc.
    • F. Hoffmann-La Roche Ltd
    • BIOMERIEUX
    • DiaSorin SpA
    • Merck KGaA
    • Quidel Corporation
    • Coris BioConcept
    • Quest Diagnostics
    • Siemens Healthcare SA
Product Code: 978-1-68038-680-6

Respiratory Syncytial Virus Diagnostics Market Growth & Trends:

The global respiratory syncytial virus diagnostics market is expected to reach USD 1947.3 million by 2030, growing at an estimated CAGR of 9.7% from 2023 to 2030, according to a new study by Grand View Research, Inc.. Increasing neonatal population suffering from respiratory conditions including RSV infections and supportive initiatives for diagnosis of newborns by the healthcare providers are expected to be vital impact rendering drivers for RSV diagnostics market.

According to the statistics provided by the WHO, hospitalization of over 150,000 children (below the age of five) and about 14,000 deaths in geriatric patients occurred in the U.S. in 2014 due to RSV infections. This is anticipated to trigger demand for testing of these conditions over the forecast period.

Furthermore, the global birth rate as of 2014 is 18.7 births per 1,000 individuals, which is predicted to increase the infant population substantially over the next seven years. According to the statistics, it is estimated that about 134.2 million births took place in 2014, which are prone to RSV infections and require diagnosis, thus forming a large market base.

In 2010, Save Babies Through Screening Foundation (SBTS) entered in a partnership with World Solutions Against Infectious Disease (WSAID) as an attempt to promote higher screening of newborns for infectious diseases, metabolic disorders, and hearing disabilities.

Respiratory Syncytial Virus Diagnostics Market Report Highlights:

  • Chromatographic immunoassay technology based products are expected to witness the fastest growth at a CAGR above 10.0% over the next seven years owing to their higher specificity than molecular diagnostic products. The commercially available test kits include Binax Now RSV, QuickLab RSV Test, Remel Xpect, and RSV Respi-Strip.
  • Hospitals are predicted to dominate the RSV diagnostics market followed by home care. Together, they are expected to contribute over 50.0% of the market share in 2022. Increasing demand for home care diagnostic devices by patients is anticipated to drive growth of the segment over the next seven years.
  • North America is anticipated to dominate the market and contribute a revenue share of over 41.5% by 2022. Rising awareness among the population base and favorable initiatives by the government agencies such as the WHO, PAHO, and WSAID to initiate and implement newborn screening are expected to drive growth.
  • Key players of the market include Alere Inc., EMD Millipore, BD and Company, Ortho Clinical Diagnostics, Roche Diagnostics, Abbott Laboratories, and Thermo Fisher Scientific Inc. CLIA waiver and launch of RSV assays by companies like Roche Diagnostics, Becton Dickinson and Company, and Alere Inc. are expected to boost market growth over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End-use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Syncytial Virus (RSV) Diagnostic Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Respiratory Syncytial Virus (RSV) Diagnostic Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Respiratory Syncytial Virus (RSV) Diagnostic Market: Product Estimates & Trend Analysis

  • 4.1. Respiratory Syncytial Virus (RSV) Diagnostic Market: Key Takeaways
  • 4.2. Respiratory Syncytial Virus (RSV) Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Direct Fluorescent Antibody (DFA) Method
    • 4.3.1. Direct fluorescent antibody (DFA) Method estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Rapid Antigen Diagnostic Test (RADT)
    • 4.4.1. Rapid Antigen Diagnostic Test (RADT) market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Molecular Diagnostics
    • 4.5.1. Molecular diagnostic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Chromatographic Immunoassay
    • 4.6.1. Chromatographic immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Diagnostic Imaging
    • 4.7.1. Diagnostic imaging Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Gel Microdroplets
    • 4.8.1. Gel microdroplets imaging immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Flow Cytometry
    • 4.9.1. Flow cytometry imaging immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Others
    • 4.10.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Respiratory Syncytial Virus (RSV) Diagnostic Market: End-use Estimates & Trend Analysis

  • 5.1. Respiratory Syncytial Virus (RSV) Diagnostic Market: Key Takeaways
  • 5.2. Respiratory Syncytial Virus (RSV) Diagnostic Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Hospitals
    • 5.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Laboratory
    • 5.4.1. Laboratory market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Clinics
    • 5.5.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Homecare
    • 5.6.1. Homecare market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Respiratory Syncytial Virus (RSV) Diagnostic Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Respiratory Syncytial Virus (RSV) Diagnostic Market by Region: Key Marketplace Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Denmark
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Norway
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Becton, Dickinson and Company
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Novartis AG
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Abbott
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Ortho Clinical Diagnostics
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Thermo Fisher Scientific Inc.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Bio-Rad Laboratories, Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. F. Hoffmann-La Roche Ltd
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. BIOMERIEUX
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. DiaSorin S.p.A.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Merck KGaA
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Quidel Corporation
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives
    • 7.2.12. Coris BioConcept
      • 7.2.12.1. Company overview
      • 7.2.12.2. Financial performance
      • 7.2.12.3. Product benchmarking
      • 7.2.12.4. Strategic initiatives
    • 7.2.13. Quest Diagnostics
      • 7.2.13.1. Company overview
      • 7.2.13.2. Financial performance
      • 7.2.13.3. Product benchmarking
      • 7.2.13.4. Strategic initiatives
    • 7.2.14. Siemens Healthcare S.A.
      • 7.2.14.1. Company overview
      • 7.2.14.2. Financial performance
      • 7.2.14.3. Product benchmarking
      • 7.2.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 North America respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 5 U.S. respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 7 Canada respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Europe respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 10 Europe respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 11 Europe respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 12 UK respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 13 UK respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 14 Germany respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 15 Germany respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 France respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 17 France respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 18 Italy respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 19 Italy respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 20 Spain respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 21 Spain respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 Denmark respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 23 Denmark respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 24 Sweden respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 25 Sweden respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 Norway respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 27 Norway respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific respiratory syncytial virus diagnostic market, by region, (USD Million) 2018 - 2030
  • Table 31 Japan respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 32 Japan respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 34 China respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 India respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 36 India respiratory syncytial virus diagnostic market, by end-use, (USD Million) 2018 - 2030
  • Table 37 Australia respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 38 Australia respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 Thailand respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 40 Thailand respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 South Korea respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 42 South Korea respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Latin America respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 44 Latin America respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 46 Brazil respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 47 Brazil respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Mexico respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 49 Mexico respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Argentina respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 51 Argentina respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East and Africa respiratory syncytial virus diagnostic market, by region, 2018 - 2030 (USD Million)
  • Table 55 South Africa respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 56 South Africa respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 UAE respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 60 UAE respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)
  • Table 61 Kuwait respiratory syncytial virus diagnostic market, by product, 2018 - 2030 (USD Million)
  • Table 62 Kuwait respiratory syncytial virus diagnostic market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Respiratory syncytial virus diagnostic: Market outlook
  • Fig. 9 Respiratory syncytial virus diagnostic: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Respiratory syncytial virus diagnostic market driver impact
  • Fig. 15 Respiratory syncytial virus diagnostic market restraint impact
  • Fig. 16 Respiratory syncytial virus diagnostic market strategic initiatives analysis
  • Fig. 17 Respiratory syncytial virus diagnostic market: Product movement analysis
  • Fig. 18 Respiratory syncytial virus diagnostic market: product outlook and key takeaways
  • Fig. 19 Direct fluorescent antibody (DFA) method market estimates and forecasts, 2018 - 2030
  • Fig. 20 Rapid antigen diagnostic test (RADT) market estimates and forecasts, 2018 - 2030
  • Fig. 21 Molecular diagnostic market estimates and forecasts, 2018 - 2030
  • Fig. 22 Chromatographic immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 23 Diagnostic imaging market estimates and forecasts, 2018 - 2030
  • Fig. 24 Gel microdroplets immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 25 Flow cytometry immunoassay market estimates and forecasts, 2018 - 2030
  • Fig. 26 Others market estimates and forecasts, 2018 - 2030
  • Fig. 27 Respiratory syncytial virus diagnostic market: End-use movement analysis
  • Fig. 28 Respiratory syncytial virus diagnostic market: End-use outlook and key takeaways
  • Fig. 29 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 30 Laboratory market estimates and forecasts, 2018 - 2030
  • Fig. 31 Clinics market estimates and forecasts, 2018 - 2030
  • Fig. 32 Homecare market estimates and forecasts, 2018 - 2030
  • Fig. 33 Global respiratory syncytial virus diagnostic market: Regional movement analysis
  • Fig. 34 Global respiratory syncytial virus diagnostic market: Regional outlook and key takeaways
  • Fig. 35 North America market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 37 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 38 Europe. market estimates and forecasts, 2018 - 2030
  • Fig. 39 UK market estimates and forecasts, 2018 - 2030
  • Fig. 40 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 41 France market estimates and forecasts, 2018 - 2030
  • Fig. 42 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 43 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 44 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 45 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 46 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 47 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 48 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 49 China market estimates and forecasts, 2018 - 2030
  • Fig. 50 India market estimates and forecasts, 2018 - 2030
  • Fig. 51 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 52 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 54 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 55 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 56 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 57 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 58 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 59 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 60 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 61 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 62 Kuwait market estimates and forecasts, 2018 - 2030